204 related articles for article (PubMed ID: 34815786)
1. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.
Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L
Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786
[No Abstract] [Full Text] [Related]
2. CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis.
Bourne JH; Beristain-Covarrubias N; Zuidscherwoude M; Campos J; Di Y; Garlick E; Colicchia M; Terry LV; Thomas SG; Brill A; Bayry J; Watson SP; Rayes J
Front Immunol; 2021; 12():693974. PubMed ID: 34163489
[TBL] [Abstract][Full Text] [Related]
3. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.
Inoue O; Hokamura K; Shirai T; Osada M; Tsukiji N; Hatakeyama K; Umemura K; Asada Y; Suzuki-Inoue K; Ozaki Y
PLoS One; 2015; 10(9):e0139357. PubMed ID: 26418160
[TBL] [Abstract][Full Text] [Related]
4. The platelet-activating receptor C-type lectin receptor-2 plays an essential role in liver regeneration after partial hepatectomy in mice.
Kono H; Fujii H; Suzuki-Inoue K; Inoue O; Furuya S; Hirayama K; Akazawa Y; Nakata Y; Sun C; Tsukiji N; Shirai T; Ozaki Y
J Thromb Haemost; 2017 May; 15(5):998-1008. PubMed ID: 28294559
[TBL] [Abstract][Full Text] [Related]
5. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
[TBL] [Abstract][Full Text] [Related]
6. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
Sheng M; Sun R; Fu J; Lu G
BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
[TBL] [Abstract][Full Text] [Related]
7. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.
Payne H; Ponomaryov T; Watson SP; Brill A
Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.
Herzog BH; Fu J; Wilson SJ; Hess PR; Sen A; McDaniel JM; Pan Y; Sheng M; Yago T; Silasi-Mansat R; McGee S; May F; Nieswandt B; Morris AJ; Lupu F; Coughlin SR; McEver RP; Chen H; Kahn ML; Xia L
Nature; 2013 Oct; 502(7469):105-9. PubMed ID: 23995678
[TBL] [Abstract][Full Text] [Related]
9. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
[TBL] [Abstract][Full Text] [Related]
10. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML
Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774
[TBL] [Abstract][Full Text] [Related]
11. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
[TBL] [Abstract][Full Text] [Related]
12. C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
Tanaka K; Tanaka M; Watanabe N; Ito M; Pastan I; Koizumi M; Matsusaka T
Sci Rep; 2022 Dec; 12(1):22356. PubMed ID: 36572741
[TBL] [Abstract][Full Text] [Related]
13. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.
Lowe KL; Finney BA; Deppermann C; Hägerling R; Gazit SL; Frampton J; Buckley C; Camerer E; Nieswandt B; Kiefer F; Watson SP
Blood; 2015 Jun; 125(24):3769-77. PubMed ID: 25908104
[TBL] [Abstract][Full Text] [Related]
15. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
[TBL] [Abstract][Full Text] [Related]
16. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
[TBL] [Abstract][Full Text] [Related]
17. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.
May F; Hagedorn I; Pleines I; Bender M; Vögtle T; Eble J; Elvers M; Nieswandt B
Blood; 2009 Oct; 114(16):3464-72. PubMed ID: 19641185
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2.
Acton SE; Astarita JL; Malhotra D; Lukacs-Kornek V; Franz B; Hess PR; Jakus Z; Kuligowski M; Fletcher AL; Elpek KG; Bellemare-Pelletier A; Sceats L; Reynoso ED; Gonzalez SF; Graham DB; Chang J; Peters A; Woodruff M; Kim YA; Swat W; Morita T; Kuchroo V; Carroll MC; Kahn ML; Wucherpfennig KW; Turley SJ
Immunity; 2012 Aug; 37(2):276-89. PubMed ID: 22884313
[TBL] [Abstract][Full Text] [Related]
19. Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse.
Lax S; Rayes J; Wichaiyo S; Haining EJ; Lowe K; Grygielska B; Laloo R; Flodby P; Borok Z; Crandall ED; Thickett DR; Watson SP
Am J Physiol Lung Cell Mol Physiol; 2017 Dec; 313(6):L1016-L1029. PubMed ID: 28839100
[TBL] [Abstract][Full Text] [Related]
20. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
